Cargando…

Role of CXCR3 signaling in response to anti-PD-1 therapy

BACKGROUND: Tumor mutations and tumor microenvironment are associated with resistance to cancer immunotherapies. However, peripheral T cell in effective anti-programmed death 1 (PD-1) antibody treatment is poorly understood. METHODS: Mass spectrometry and conventional flow cytometry were used to inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Xiao, Wang, Ying, Sun, Jing, Tan, Tao, Cai, Xiaomin, Lin, Peinan, Tan, Yang, Zheng, Bingfeng, Wang, Biao, Wang, Jiawei, Xu, Lingyan, Yu, Zhengyi, Xu, Qiang, Wu, Xingxin, Gu, Yanhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838359/ https://www.ncbi.nlm.nih.gov/pubmed/31521609 http://dx.doi.org/10.1016/j.ebiom.2019.08.067

Ejemplares similares

Comparison of different chemoradiotherapy regimens for the preoperative treatment in patients with locally advanced rectal cancer: a network meta-analysis
por: Yu, Zhengyi, et al.
Publicado: (2020)

Methylenetetrahydrofolate reductase C677T polymorphism and colorectal cancer susceptibility: a meta-analysis
por: Xu, Lingyan, et al.
Publicado: (2017)

Analysis of pemetrexed-based chemotherapy in the treatment of advanced colorectal cancer
por: Yu, Zhengyi, et al.
Publicado: (2020)

Apatinib suppresses tumor progression and enhances cisplatin sensitivity in esophageal cancer via the Akt/β-catenin pathway
por: Wei, Bin, et al.
Publicado: (2020)

CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy
por: Li, Xiaofei, et al.
Publicado: (2022)

Dose-escalation of oxaliplatin in hemodialysis patient treated with FOLFOX therapy: A case report
por: Wang, Danping, et al.
Publicado: (2019)

Uric acid preconditioning alleviated doxorubicin induced JNK activation and Cx43 phosphorylation associated cardiotoxicity via activation of AMPK-SHP2 signaling pathway
por: Wang, Jiawei, et al.
Publicado: (2020)

CXCR6 is required for antitumor efficacy of intratumoral CD8(+) T cell
por: Wang, Binglin, et al.
Publicado: (2021)

Mitochondrial folate metabolism–mediated α-linolenic acid exhaustion masks liver fibrosis resolution
por: Gao, Yanjie, et al.
Publicado: (2023)

Interferon gamma inhibits CXCL8–CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer
por: Zhang, Mingjie, et al.
Publicado: (2020)

Structural basis of the therapeutic anti-PD-L1 antibody atezolizumab
por: Zhang, Fei, et al.
Publicado: (2017)

SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients
por: Mei, Zhu, et al.
Publicado: (2018)

Molecular Mechanism of Small-Molecule Inhibitors in Blocking the PD-1/PD-L1 Pathway through PD-L1 Dimerization
por: Guo, Yan, et al.
Publicado: (2021)

Landscape of SARS-CoV-2 spike protein-interacting cells in human tissues
por: Zheng, Bingfeng, et al.
Publicado: (2021)

Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti–PD-L1 immunotherapy
por: Li, Zhaoting, et al.
Publicado: (2020)

Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1
por: D’Alterio, Crescenzo, et al.
Publicado: (2019)

A Single‐Arm, Phase II Study of Apatinib in Refractory Metastatic Colorectal Cancer
por: Chen, Xiaofeng, et al.
Publicado: (2019)

Cost-Effectiveness of Ipilimumab Plus Anti-PD-1 Therapy Versus Ipilimumab Alone in Patients With Metastatic Melanoma Resistant to Anti-PD-(L)1 Monotherapy
por: Peng, Ye, et al.
Publicado: (2021)

Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer
por: Wu, Weidong, et al.
Publicado: (2016)

Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker
por: Wang, Zhengyi, et al.
Publicado: (2020)

CXCR7 regulates epileptic seizures by controlling the synaptic activity of hippocampal granule cells
por: Xu, Tao, et al.
Publicado: (2019)

The role of SDF-1/CXCR4 in the vasculogenesis and remodeling of cerebral arteriovenous malformation
por: Wang, Lingyan, et al.
Publicado: (2015)

Prognostic Value and Therapeutic Perspectives of CXCR Members in the Glioma Microenvironment
por: He, Jiarong, et al.
Publicado: (2022)

Mesenchymal Stem Cells Attract Endothelial Progenitor Cells via a Positive Feedback Loop between CXCR2 and CXCR4
por: Tan, Yingyun, et al.
Publicado: (2019)

Evaluation on Anti-Inflammatory, Analgesic, Antitumor, and Antioxidant Potential of Total Saponins from Nigella glandulifera Seeds
por: Zhao, Jun, et al.
Publicado: (2013)

CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients
por: D’Alterio, Crescenzo, et al.
Publicado: (2022)

CXCR7 promotes melanoma tumorigenesis via Src kinase signaling
por: Xu, Siran, et al.
Publicado: (2019)

SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade
por: Zhao, Mingxia, et al.
Publicado: (2019)

The role of CXCR7 on the adhesion, proliferation and angiogenesis of endothelial progenitor cells
por: Dai, Xiaozhen, et al.
Publicado: (2011)

Small molecule targeting CELF1 RNA-binding activity to control HSC activation and liver fibrosis
por: Tan, Yang, et al.
Publicado: (2022)

CXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression
por: Lin, L, et al.
Publicado: (2014)

Higher Frequency of Circulating PD-1(high) CXCR5(+)CD4(+) Tfh Cells in Patients with Chronic Schistosomiasis
por: Zhang, Yumei, et al.
Publicado: (2015)

Correlation of CXCR4/CXCR7 signaling pathway with pre-eclampsia
por: Zheng, Zhi, et al.
Publicado: (2018)

Antimetastasis Effect of Astragalus membranaceus-Curcuma zedoaria via β-Catenin Mediated CXCR4 and EMT Signaling Pathway in HCT116
por: Tan, Xiying, et al.
Publicado: (2019)

CUG-binding protein 1 regulates HSC activation and liver fibrogenesis
por: Wu, Xingxin, et al.
Publicado: (2016)

Single-cell analyses reveal cannabidiol rewires tumor microenvironment via inhibiting alternative activation of macrophage and synergizes with anti-PD-1 in colon cancer
por: Sun, Xiaofan, et al.
Publicado: (2023)

Regulative role of the CXCL13-CXCR5 axis in the tumor microenvironment
por: Tan, Ping, et al.
Publicado: (2018)

Increased frequency of PD-1(hi)CXCR5(-) T cells and B cells in patients with newly diagnosed IgA nephropathy
por: Wang, Xin, et al.
Publicado: (2020)

Preclinical to clinical translation of anti-PD-1 blockade
por: Hirsch, Heather, et al.
Publicado: (2015)

Anti-tumor activity of nanomicelles encapsulating CXCR4 peptide antagonist E5
por: Fang, Xiaocui, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_l5j92f3eq1lfplc16ru8a47nl1